FDA — authorised 17 March 2010
- Application: ANDA079043
- Marketing authorisation holder: DR REDDYS LABS LTD
- Status: supplemented
🇺🇸 Fexofenadine HCL and pseudoephedrine HCL in United States
FDA authorised Fexofenadine HCL and pseudoephedrine HCL on 17 March 2010
Marketing authorisation
Other Allergy/Immunology approved in United States
Frequently asked questions
Is Fexofenadine HCL and pseudoephedrine HCL approved in United States?
Yes. FDA authorised it on 17 March 2010.
Who is the marketing authorisation holder for Fexofenadine HCL and pseudoephedrine HCL in United States?
DR REDDYS LABS LTD holds the US marketing authorisation.